A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI

BACKGROUND: The VELOUR study demonstrated a survival benefit for FOLFIRI + aflibercept versus FOLFIRI + placebo in metastatic colorectal cancer (mCRC) patients who progressed on oxaliplatin-based chemotherapy. Continued divergence of overall survival (OS) curves in the intension to treat (ITT) popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Chau, Ian, Joulain, Florence, Iqbal, Sheikh Usman, Bridgewater, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149045/
https://www.ncbi.nlm.nih.gov/pubmed/25142418
http://dx.doi.org/10.1186/1471-2407-14-605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149045/
https://www.ncbi.nlm.nih.gov/pubmed/25142418
http://dx.doi.org/10.1186/1471-2407-14-605

Ejemplares similares